What is it about?
An achiral organic molecule adopts a chiral conformation, due to rotation about sigma bonds, when it crystallizes. At low temperatures (below 70 deg C), there is a 50:50 (i.e., racemic) mixture of the two possible enantiomers in the crystal. Above 70 deg C, there is a phase transition to a new crystal structure in which all the molecules in a single crystal are of only one enantiomer (i.e., there is chiral resolution). This phase transition is completely reversible.
Featured Image
Why is it important?
"Handedness" (i.e., chirality) can have an enormous impact on the physiological effects of a pharmaceutical chemical. Crystal morphology can have a huge impact on solubility, bioavailability, and efficacy of a pharmaceutical chemical. The system reported in this paper represents a unique combination of attributes associated with morphological behaviour and chirality. It can be used as a benchmark example of how supramolecular interactions can be used to understand/manipulate chiral resolution and phase behaviour.
Read the Original
This page is a summary of: Reversible crystal-to-crystal chiral resolution: making/breaking non-bonding S⋯O interactions, Chemical Communications, January 2017, Royal Society of Chemistry,
DOI: 10.1039/c7cc00907k.
You can read the full text:
Contributors
The following have contributed to this page